THE PHARMA MANAGED MARKETS SUMMIT HAS BEEN CANCELLED AND ITS CONTENTS RESCHEDULED FOR THE
PFC PHARMA CONGRESS
KEYNOTE SPEAKERS
Catherine Davis Ahmed, MBA
Director of Policy and Outreach, Familial Hypercholesterolemia Foundation
Washington, DC
Jim Clement, MHA
Executive Director, Cost of Care & Supply Chain Strategy, Aetna; Former National Account Manager, PBMs & Specialty Pharmacy, Genentech, Inc., Former Director, Pharmaceutical Contracting, Express Scripts, Inc., Hartford, CT
Susan Dentzer
President and Chief Executive Officer, NEHI (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Washington, DC
Michelle Drozd, ScM
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC
David Hartenbaum, MD, MBA
Executive Director, Account Management, Merck, Philadelphia, PA
Edmund Pezalla, MD, PHD
CEO, Enlightenment Bioconsulting; Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy, Aetna; Hartford, CT
Gregg Shapiro, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
Surya Singh, MD
Executive Vice President and Chief Medical Officer, CVS/Specialty, Boston, MA
Julie Ritchie Wagner
Assistant General Counsel, PhRMA, Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
FEATURING SESSIONS ON
- View from the Marketplace: Rewarding Results: Moving Forward for Value-Based Contracting for Biopharmaceuticals
- A Prosecutor’s Perspective
- PhRMA’s Perspective on Public Policy Considerations for Expanding Value-Based Contracting
- Recent FDA Draft Guidances on Manufacturer Communications and the Memorandum on Off-Label Communications
- OIG’s Special Advisory Bulletin and Advisory Opinions on Charity Pharmaceutical Patient Assistance Programs
- Enforcement Trends, Risk Assessments, and Best Practices in Compliance Controls for Patient Services Programs
- Pre-Approval Information Exchange with Payors
- Considerations for Hubs and Specialty Pharmacy Arrangements
- Considerations for Value-Based Contracting
- Risk-Sharing Arrangements for Pharmaceuticals and Medical Devices: Anti-Trust and FDA Regulatory Issues
- Collaboration to Advance Value Frameworks
- Pricing Transparency and New Proposed Models for Pharmaceutical Pricing
- Implications of the Evolving Landscape on Government Price Reporting
- Compliance Program Considerations Applicable to the Managed Markets Business
FEATURED FACULTY
Eliza L. Andonova, JD
Counsel, Hogan Lovells, Washington, DC
Susan Asante-Abedi, MS
Senior Principal, QuintilesIMS, New York, NY
Thomas W. Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Us Department of Health and Human Services, Minneapolis, MN
Blake Bolinger, JD
Director, US Pharmaceuticals, Compliance and Ethics, Bristol-Myers Squibb, Princeton Pike, NJ
Carla Brooks, MS
Director, Compliance, Market Access and Government Affairs, AstraZeneca, Gaithersburg, MD
Terra Buckley
Director, Compliance, Helsinn Therapeutics (U.S.), Inc., Former Director, Ethics & Compliance, North America, Ipsen, Former Associate Director, Compliance, Aptalis Pharma/Forest Laboratories, Iselin, NJ
Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, Princeton Pike, NJ
Chris Cobourn, MA
Managing Director, Huron Consulting Group, Philadelphia, PA
Kellie B. Combs, JD
Partner, Ropes & Gray, Washington, DC
Meenakshi Datta, JD
Partner, Sidley Austin LLP, Chicago, IL
Mark DeWyngaert, MBA, PhD
Managing Director, Huron Life Sciences, New York, NY
Laura Hoey, JD
Partner, Ropes & Gray, Former Assistant United States Attorney, US Attorney’s Office in the Eastern District of Arkansas, Chicago, IL
Casey Horton
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, Former Director, Compliance Operations, AbbVie, Chicago, IL
Vasiliki Kalaitzidis, JD
Associate General Counsel, Managed Markets and Operations, EMD Serono, Rockland, MA
Thomas Kidd
Advisor, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN
John Linehan, JD
Healthcare Attorney, Epstein Becker Green, Former Special Assistant US Attorney, US Attorney’s Office for the District of Maryland, Washington, DC
Seth H. Lundy, JD
Partner, King & Spalding, Washington, DC
Stephen Paul Mahinka, Esq.
Partner, Morgan, Lewis & Bockius LLP, Washington, DC
Soumi Saha, JD, PharmD
Assistant Director of Pharmacy and Regulatory Affairs, Academy of Managed Care Pharmacy (AMCP), Former Director of National Pharmacy Controls, Kaiser Permanente, Alexandria, VA
John Shakow, JD
Partner, FDA and Life Sciences Practice, King & Spalding, Vice Chair, ABA Health Care Contracting Committee, Washington, DC
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 – 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
May 14 – 16, 2018
Hotel Savoyen
Vienna, Austria
www.InternationalPharmaCongress.com
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 2018
Singapore
www.AsianPharmaCongress.com
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
International Society of Health-
care Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Fall 2018
Mumbai, India
Coming Soon